InsiderTrades

Form 4 for PTCT PTC THERAPEUTICS, INC.

Accepted 2025-11-26 00:00:00 ET · period of report 2025-11-24 · accession 0001578850-25-000006 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-11-26 2025-11-24 PTCT Almstead Neil Gregory CHIEF TECHNICAL OPS Off M - OptEx $30.23 +35.6K 106.7K +50% +$1.08M
DM 2025-11-26 2025-11-24 PTCT Almstead Neil Gregory CHIEF TECHNICAL OPS Off S - Sale+OE $80.18 -35.6K 100.6K -26% -$2.85M
DM 2025-11-26 2025-11-24 PTCT Almstead Neil Gregory CHIEF TECHNICAL OPS Off M - OptEx $0.00 -35.6K 11.4K -76% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-11-24 M A 1,900 $18.01 102,525 D — —
2 Common Common Stock 2025-11-24 S D 1,900 $80.14 100,625 D — — (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.55 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2025-11-24 M A 1,650 $33.02 102,275 D — —
4 Common Common Stock 2025-11-24 S D 1,650 $80.14 100,625 D — — (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.14 to $80.48 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
5 Common Common Stock 2025-11-24 M A 4,715 $18.01 105,340 D — —
6 Common Common Stock 2025-11-24 S D 4,715 $80.15 100,625 D — — (F4) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.68 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
7 Common Common Stock 2025-11-24 M A 21,206 $33.02 121,831 D — —
8 Common Common Stock 2025-11-24 S D 21,206 $80.19 100,625 D — — (F5) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
9 Common Common Stock 2025-11-24 M A 6,101 $33.02 106,726 D — —
10 Common Common Stock 2025-11-24 S D 6,101 $80.17 100,625 D — — (F6) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.56 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
11 Derivative Stock Option (Right to Buy) 2025-11-24 M D 1,900 $0.00 15,600 D $18.01 · — to 2028-01-02 1,900 Common Stock (F7) Currently exercisable.
12 Derivative Stock Option (Right to Buy) 2025-11-24 M D 1,650 $0.00 70,850 D $33.02 · — to 2029-01-21 1,650 Common Stock (F7) Currently exercisable.
13 Derivative Stock Option (Right to Buy) 2025-11-24 M D 4,715 $0.00 10,885 D $18.01 · — to 2028-01-02 4,715 Common Stock (F7) Currently exercisable.
14 Derivative Stock Option (Right to Buy) 2025-11-24 M D 21,206 $0.00 49,644 D $33.02 · — to 2029-01-21 21,206 Common Stock (F7) Currently exercisable.
15 Derivative Stock Option (Right to Buy) 2025-11-24 M D 6,101 $0.00 11,399 D $33.02 · — to 2029-01-21 6,101 Common Stock (F7) Currently exercisable.